Eden Research (LON:EDEN) Sets New 12-Month Low – What’s Next?

Posted by Scott Moore on Mar 27th, 2025

Eden Research plc (LON:EDEN – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Thursday . The company traded as low as GBX 2.75 ($0.04) and last traded at GBX 2.90 ($0.04), with a volume of 281615 shares trading hands. The stock had previously closed at GBX 2.93 ($0.04).

Eden Research Stock Performance

The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The firm has a market capitalization of £15.47 million, a P/E ratio of -10.16 and a beta of 0.92. The company’s 50 day moving average is GBX 3.46 and its 200-day moving average is GBX 3.75.

Insider Transactions at Eden Research

In other Eden Research news, insider Alexander John Abrey purchased 167,947 shares of the firm’s stock in a transaction on Tuesday, March 4th. The stock was acquired at an average price of GBX 3 ($0.04) per share, for a total transaction of £5,038.41 ($6,486.94). Also, insider Lykele van der Broek acquired 256,000 shares of the company’s stock in a transaction on Thursday, February 6th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($13,183.98). Insiders have purchased 964,487 shares of company stock valued at $3,690,001 in the last 90 days. 14.02% of the stock is currently owned by corporate insiders.

About Eden Research

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.